Neumora Therapeutics Inc. Company Profile
NASDAQ: NMRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4683-0.0027 (-0.57%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Neumora Therapeutics at a glance
Neumora Therapeutics Inc. (NASDAQ: NMRA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2023. At a market capitalization of $88.5 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001885522, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Neumora Therapeutics Inc.
- Ticker
- NASDAQ: NMRA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2023
- Market cap
- $88.50M
- SEC CIK
- 0001885522
Companies similar to Neumora Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CGTXCognition Therapeutics Inc. | 0.9366 | -0.36% | $89.06M | vs NMRA |
| CRDFCardiff Oncology Inc. | 1.09 | +1.87% | $84.80M | vs NMRA |
| ATRAAtara Biotherapeutics Inc. | 9.37 | -3.90% | $94.05M | vs NMRA |
| PTHSPelthos Therapeutics Inc. | 20.99 | -2.28% | $80.36M | vs NMRA |
| GRMLGreenland Mines Ltd. | 5.83 | -8.62% | $77.81M | vs NMRA |
| OKYOOKYO Pharma Limited | 1.41 | -3.42% | $74.00M | vs NMRA |
| BDTXBlack Diamond Therapeutics Inc. | 1.83 | +1.67% | $104.86M | vs NMRA |
| CSBRChampions Oncology Inc. | 4.88 | -2.59% | $67.92M | vs NMRA |